Full Press Release Details
Healthcare Appoints Eric Sachetta to its Board of Directors
financial executive brings leadership acumen, strategic growth expertise
and a strong track record of operational excellence
RATON, Fla. (November 12, 2025) - Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective,
non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the
appointment of Eric Sachetta to the Company's Board of Directors. Mr. Sachetta is filling the vacancy that resulted from
the passing of long-serving Director Bill McCall.
his career, Mr. Sachetta has held a range of leadership roles focused on organizational growth, team development, sales performance and
operational improvement. He currently serves as Chief Wealth Services Officer of Sachetta, LLC, a financial advisory firm based
in Lynnfield, Mass., where he leads firmwide advisory strategy, operational oversight, financial planning innovation and multi-disciplinary
client service execution. Since 2022, he has led and managed the firm's financial advisory division, overseeing all wealth management
operations and mentoring emerging advisors to achieve production goals.
in his career he founded and led The E TEAM, a nationwide motivational speaking and leadership development organization that reached
more than 140 schools and youth programs across 12 states. He also served as author and curriculum creator for "The 8 Mandates
of Personal Leadership," a personal development framework used by students and coaches across the U.S.
have been closely following Sensus Healthcare for many years and am impressed with the company's commitment to patient care and
superior clinical outcomes through the delivery of non-invasive treatments for non-melanoma skin cancer and keloids," said Mr.
Sachetta. "Sensus has an outstanding leadership team and I look forward to contributing to the long-term success of the company."
are delighted to welcome Eric to our Board and look forward to his contributions," said Joe Sardano, Chairman and Chief Executive
Officer of Sensus Healthcare. "Eric brings a strong financial background, deep experience leading organizations through growth
and transition and a clear appreciation for the mission of our company. We believe that his combination of strategic insight and people-focused
leadership will add meaningful value as we continue expanding the reach of our SRT technology and advancing our global vision."
Sachetta holds a Bachelor of Science in Corporate Finance & Accounting from Bentley University. He is a Certified
Financial Planner (CFP ), Chartered Financial Consultant (ChFC ), Tax Planning Certified Professional (TPCP ) and
holds a Series 65 investment advisory license.
Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging
its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective,
patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions
that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com.
press release includes statements that are, or may be deemed, ''forward-looking statements.'' In some cases, these statements can be
identified by the use of forward-looking terminology such as "believes," "estimates," "anticipates," "expects,"
"plans," "intends," "may," "could," "might," "will," "should,"
"approximately," "potential" or negative or other variations of those terms or comparable terminology, although
not all forward-looking statements contain these words.
statements involve risks and uncertainties because they relate to events, developments, and circumstances relating to Sensus, our industry,
and/or general economic or other conditions that may or may not occur in the future or may occur on longer or shorter timelines or to
a greater or lesser degree than anticipated. In addition, even if future events, developments, and circumstances are consistent with
the forward-looking statements contained in this press release, they may not be predictive of results or developments in future periods.
Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, forward-looking
statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity, and the
development of the industry in which we operate may differ materially from the forward-looking statements contained in this press release,
as a result of the following factors, among others: the possibility that inflationary pressures continue to impact our sales; the
level and availability of government and/or third party payor reimbursement for clinical procedures using our products, and the willingness
of healthcare providers to purchase our products if the level of reimbursement declines; concentration of our customers in the U.S. and
China, including the concentration of sales to one particular customer in the U.S.; the development by others of new products, treatments,
or technologies that render our technology partially or wholly obsolete; the regulatory requirements applicable to us and our competitors;
our ability to efficiently manage our manufacturing processes and costs; the risks arising from doing business in China and other foreign
countries; legislation, regulation, or other governmental action that affects our products, taxes, international trade regulation, or
other aspects of our business; the performance of the Company's information technology systems and its ability to maintain data
security; our ability to obtain and maintain the intellectual property needed to adequately protect our products, and our ability to
avoid infringing or otherwise violating the intellectual property rights of third parties; and other risks described from time to time
in our filings with the Securities and Exchange Commission, including our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.
forward-looking statements that we make in this press release speak only as of the date of such statement, and we undertake no obligation
to update such statements to reflect events or circumstances after the date of this press release, except as may be required by applicable
law. You should read carefully our "Introductory Note Regarding Forward-Looking Information" and the factors described in the
"Risk Factors" section of our periodic reports filed with the Securities and Exchange Commission to better understand the risks
and uncertainties inherent in our business.